This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

They Just Don't Get Clorox!

WESTCHESTER COUNTY, N.Y. (TheStreet) -- When it comes to the reporting of merger rumors, it is too easy for a shaky premise to take shape in a headline. You need to look no further than an article this week in The New York Post (NWS - Get Report) about Clorox (CLX - Get Report). Other media outlets picked up and ran with the story and plenty on the Internet were braying about the possibility.

But there was little there to meet the eye. A quick look at the article holds a cautionary lesson.

First, we are told in the lead: "Clorox has caught the eye of at least one potential buyer, The Post has learned." The passive voice should raise a brow. Linguistically, it's a distancing mechanism. If there were several sources close to the negotiations actively asserting that Clorox might be gobbled up by a Japanese consumer product company, we'd hear it in an active voice. The Post's one source? Unnamed. Worse, we don't even get a sense of how--if at all--the source is involved in the proceedings. To believe such an article, you need a clue strewn about.

Later, we hear that Kao, the Japanese firm, "is looking at Clorox." Weak. Within industries, everyone "looks" at everyone. Moreover, in this case Carl Icahn put Clorox in play with a bid.

It's a pretty safe guess that everyone from Kimberly- Clark (KMB - Get Report) to Colgate Palmolive (CL - Get Report) to Procter & Gamble (PG - Get Report) is "looking at Clorox." At what level, and to what degree of seriousness, is another matter altogether.
At the time of publication, Fuchs had no positions in any of the stocks mentioned in this column.

Marek Fuchs was a stockbroker for Shearson Lehman Brothers and a money manager before becoming a journalist who wrote The New York Times' "County Lines" column for six years. He also did back-up beat coverage of The New York Knicks for the paper's Sports section for two seasons and covered other professional and collegiate sports. He has contributed frequently to many of the Times' other sections, including National, Metro, Escapes, Style, Real Estate, Arts & Leisure, Travel, Money & Business, Circuits and the Op-Ed Page. For his "Business Press Maven´┐Ż column on how business and finance are covered by the media, Fuchs was named best business journalist critic in the nation by the Talking Biz website at The University of North Carolina School of Journalism and Mass Communication. Fuchs is a frequent speaker on the business media, in venues ranging from National Public Radio to the annual conference of the Society of American Business Editors and Writers. Fuchs appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CLX $127.54 0.00%
CL $65.70 0.00%
KMB $128.63 0.00%
NWS $11.27 0.00%
PG $80.99 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs